abelheira schreef op 23 maart 2020 16:56:
"Beste Forum leden, een update:,
The COVID-19 pandemic continues to spread, and in our commitment to provide transparency to our stakeholders, I want to share an update on our clinical trials.
It was decided to pause enrolment into the filgotinib trials in order to help protect patient safety. This includes the Phase 2 and Phase 3 trials of filgotinib in Crohn’s disease (DIVERSITY), the Phase 3 in psoriatic arthritis (SELECTION), the Phase 2 trial in uveitis, and
the MANTA and MANTA-RAy trials."
Waar ik mij een beetje zorgen over maak is indien er nog geen resultaten zijn over de Manta studie, de kans op goedkeuring filgo zonder BB blijft.